TARA
Protara Therapeutics, Inc.
Company overview
- Market capitalization
- $192.06M
- Employees
- 46
- Latest publication
- 2026-09-29
About Protara Therapeutics, Inc.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 332,000USD | 0USD | 0USD |
| Cost Of Revenue | 90,000USD | 93,000USD | 88,000USD | 98,000USD | 83,000USD | — | 84,000USD | 83,000USD |
| Gross Profit | -90,000USD | -93,000USD | -88,000USD | -98,000USD | -83,000USD | 166,000USD | -84,000USD | -83,000USD |
| Research Development | 13,472,000USD | 13,124,000USD | 9,591,000USD | 10,770,000USD | 9,148,000USD | 9,499,000USD | 8,070,000USD | 6,387,000USD |
| Selling General Administrative | 6,067,000USD | 5,955,000USD | 5,169,000USD | 5,816,000USD | 4,976,000USD | 4,813,000USD | 4,260,000USD | 4,274,000USD |
| Total Operating Expenses | 19,539,000USD | 19,079,000USD | 14,760,000USD | 16,586,000USD | 14,124,000USD | 14,312,000USD | 12,330,000USD | 10,661,000USD |
| Operating Income | -19,629,000USD | -19,079,000USD | -14,760,000USD | -16,586,000USD | -14,124,000USD | -14,312,000USD | -12,330,000USD | -10,661,000USD |
| Interest Income | 1,839,000USD | 1,503,000USD | 1,495,000USD | 1,612,000USD | 1,721,000USD | 1,148,000USD | 1,103,000USD | 1,137,000USD |
| Interest Expense | 1,847,000USD | — | 1,502,000USD | 1,626,000USD | 1,729,000USD | — | — | — |
| Net Interest Income | 1,839,000USD | 1,503,000USD | 1,495,000USD | 1,612,000USD | 1,721,000USD | 1,148,000USD | 1,103,000USD | 1,137,000USD |
| Income Before Tax | -17,782,000USD | -17,307,000USD | -13,258,000USD | -14,960,000USD | -11,914,000USD | -12,769,000USD | -11,219,000USD | -9,513,000USD |
| Net Income | -17,782,000USD | -17,307,000USD | -13,258,000USD | -14,960,000USD | -11,914,000USD | -12,769,000USD | -11,219,000USD | -9,513,000USD |
| Net Income From Continuing Ops | -17,782,000USD | -17,307,000USD | -13,258,000USD | -14,960,000USD | -11,914,000USD | -12,769,000USD | -11,219,000USD | -9,513,000USD |
| Ebit | -19,629,000USD | -19,079,000USD | -14,760,000USD | -16,586,000USD | -14,124,000USD | -14,312,000USD | -12,330,000USD | -10,661,000USD |
| Ebitda | -19,539,000USD | -18,986,000USD | -14,672,000USD | -16,488,000USD | -14,041,000USD | -14,230,000USD | -12,246,000USD | -10,578,000USD |
| Depreciation And Amortization | 90,000USD | 93,000USD | 88,000USD | 98,000USD | 83,000USD | 82,000USD | 84,000USD | 83,000USD |
| Reconciled Depreciation | 90,000USD | 93,000USD | 88,000USD | 98,000USD | 83,000USD | 82,000USD | 84,000USD | 83,000USD |
| Total Other Income Expense Net | 1,847,000USD | 1,772,000USD | 1,502,000USD | 1,626,000USD | 2,210,000USD | 1,543,000USD | 1,111,000USD | 1,148,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 362,000USD | 332,000USD | 341,000USD | 247,000USD | 1,167,000USD | 196,000USD | 16,000USD | 115,000USD |
| Gross Profit | -362,000USD | -332,000USD | -341,000USD | -247,000USD | -1,167,000USD | -196,000USD | -16,000USD | -115,000USD |
| Research Development | 42,633,000USD | 31,704,000USD | 24,785,000USD | 16,808,000USD | 21,088,000USD | 11,883,000USD | 6,438,000USD | 15,506,000USD |
| Selling General Administrative | 21,916,000USD | 17,450,000USD | 18,624,000USD | 20,737,000USD | 26,401,000USD | 22,462,000USD | 8,816,000USD | 10,574,000USD |
| Total Operating Expenses | 64,187,000USD | 49,154,000USD | 43,272,000USD | 67,062,000USD | 47,489,000USD | 34,248,000USD | 15,254,000USD | 26,080,000USD |
| Operating Income | -64,549,000USD | -49,154,000USD | -43,613,000USD | -67,062,000USD | -47,489,000USD | -34,444,000USD | -15,254,000USD | -26,080,000USD |
| Interest Income | 6,331,000USD | 4,135,000USD | 2,999,000USD | 2,230,000USD | 1,974,000USD | 500,000USD | 262,000USD | 436,000USD |
| Net Interest Income | 6,331,000USD | 4,135,000USD | 2,892,000USD | 1,093,000USD | 237,000USD | 466,000USD | — | — |
| Income Before Tax | -57,439,000USD | -44,596,000USD | -40,420,000USD | -65,952,000USD | -47,252,000USD | -33,978,000USD | -14,992,000USD | -25,437,000USD |
| Net Income | -57,439,000USD | -44,596,000USD | -40,420,000USD | -65,952,000USD | -47,252,000USD | -33,978,000USD | -14,992,000USD | -25,437,000USD |
| Net Income From Continuing Ops | -57,439,000USD | -44,596,000USD | -69,166,000USD | -65,952,000USD | -47,252,000USD | -33,978,000USD | -14,992,000USD | -20,729,000USD |
| Ebit | -64,549,000USD | -49,154,000USD | -43,613,000USD | -64,815,000USD | -45,515,000USD | -33,978,000USD | -7,830,000USD | -20,729,000USD |
| Ebitda | -64,187,000USD | -48,822,000USD | -43,272,000USD | -64,567,000USD | -45,398,000USD | -33,782,000USD | -7,814,000USD | -20,614,000USD |
| Depreciation And Amortization | 362,000USD | 332,000USD | 341,000USD | 248,000USD | 117,000USD | 196,000USD | 16,000USD | 115,000USD |
| Reconciled Depreciation | 362,000USD | 332,000USD | 309,000USD | 248,000USD | 117,000USD | 196,000USD | 279,000USD | 115,000USD |
| Total Other Income Expense Net | 7,110,000USD | 4,558,000USD | 3,193,000USD | 1,110,000USD | 237,000USD | 466,000USD | 262,000USD | 643,000USD |
| Interest Expense | — | 4,171,000USD | — | 1,137,000USD | 1,737,000USD | 34,000USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | 137,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | -341,000USD | -1,137,000USD | -117,000USD | -466,000USD | -262,000USD | 5,351,000USD |
| Unclassified Operating Expenses | — | — | — | 29,517,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -65,952,000USD | -47,252,000USD | -33,978,000USD | -14,992,000USD | -20,729,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | 262,000USD | 643,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 176,093,000USD | 191,923,000USD | 209,468,000USD | 144,636,000USD | 156,933,000USD | 168,559,000USD | 181,454,000USD | 94,090,000USD |
| Cash And Equivalents | 17,076,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 142,494,000USD | 135,786,000USD | 155,554,000USD | 132,670,000USD | 122,216,000USD | 124,363,000USD | 170,292,000USD | 81,499,000USD |
| Short Term Investments | 125,418,000USD | 121,049,000USD | 105,897,000USD | 120,119,000USD | 90,720,000USD | 32,902,000USD | 7,494,000USD | 29,742,000USD |
| Long Term Investments | 19,356,000USD | 41,641,000USD | 42,336,000USD | 957,000USD | 23,392,000USD | 33,154,000USD | 0USD | — |
| Total Current Assets | 146,152,000USD | 139,997,000USD | 159,504,000USD | 135,644,000USD | 125,091,000USD | 126,532,000USD | 172,155,000USD | 85,082,000USD |
| Other Current Assets | 230,000USD | 4,211,000USD | 2,693,000USD | 1,973,000USD | 1,985,000USD | 1,801,000USD | 1,863,000USD | 3,583,000USD |
| Other Non Current Assets | 74,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 14,782,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 13,319,000USD | 8,922,000USD | 10,939,000USD | 9,909,000USD | 9,761,000USD | 7,018,000USD | 10,961,000USD | 8,642,000USD |
| Other Current Liabilities | 7,370,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 161,311,000USD | 181,208,000USD | 196,412,000USD | 132,291,000USD | 144,423,000USD | 158,484,000USD | 167,134,000USD | 81,791,000USD |
| Total Equity Including Noncontrolling Interest | 161,311,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 3,920,000USD | 3,560,000USD | 3,933,000USD | 4,280,000USD | 4,637,000USD | 4,980,000USD | 5,282,000USD | 5,623,000USD |
| Accounts Payable | 4,663,000USD | 4,031,000USD | 3,468,000USD | 4,504,000USD | 5,299,000USD | 2,310,000USD | 4,429,000USD | 2,295,000USD |
| Short Term Debt | 1,286,000USD | 1,264,000USD | 1,242,000USD | 1,220,000USD | 1,199,000USD | 1,170,000USD | 1,124,000USD | 1,079,000USD |
| Common Stock | 59,000USD | 55,000USD | 54,000USD | 39,000USD | 39,000USD | 39,000USD | 35,000USD | 21,000USD |
| Retained Earnings | -341,869,000USD | -320,201,000USD | -302,419,000USD | -285,112,000USD | -271,854,000USD | -256,894,000USD | -244,980,000USD | -232,211,000USD |
| Accumulated Other Comprehensive Income | -363,000USD | -364,000USD | 90,000USD | 143,000USD | 77,000USD | 89,000USD | 2,000USD | 29,000USD |
| Intangible Assets | — | 5,904,000USD | 2,930,000USD | 2,989,000USD | 3,039,000USD | 3,113,000USD | 3,245,000USD | 2,539,000USD |
| Total Liab | — | 10,715,000USD | 13,056,000USD | 12,345,000USD | 12,510,000USD | 10,075,000USD | 14,320,000USD | 12,299,000USD |
| Other Current Liab | — | 3,627,000USD | 6,229,000USD | 4,185,000USD | 3,263,000USD | 3,538,000USD | 5,408,000USD | 5,268,000USD |
| Capital Stock | — | 55,000USD | 54,000USD | 39,000USD | 39,000USD | 39,000USD | 35,000USD | 21,000USD |
| Cash | — | 14,737,000USD | 49,657,000USD | 12,551,000USD | 31,496,000USD | 91,461,000USD | 162,798,000USD | 51,757,000USD |
| Net Debt | — | -11,680,000USD | -46,298,000USD | -8,895,000USD | -27,548,000USD | -87,234,000USD | -158,315,000USD | -47,021,000USD |
| Short Long Term Debt Total | — | 3,057,000USD | 3,359,000USD | 3,656,000USD | 3,948,000USD | 4,227,000USD | 4,483,000USD | 4,736,000USD |
| Property Plant Equipment Gross | — | 3,560,000USD | 5,401,000USD | 4,280,000USD | 4,637,000USD | 4,980,000USD | 6,388,000USD | 5,623,000USD |
| Common Stock Shares Outstanding | — | 42,836,129shares | 46,041,210shares | 42,272,104shares | 42,270,855shares | 40,707,937shares | 26,432,563shares | 22,329,772shares |
| Non Current Assets Total | — | 51,926,000USD | 49,964,000USD | 8,992,000USD | 31,842,000USD | 42,027,000USD | 9,299,000USD | 9,008,000USD |
| Non Current Liabilities Total | — | 1,793,000USD | 2,117,000USD | 2,436,000USD | 2,749,000USD | 3,057,000USD | 3,359,000USD | 3,657,000USD |
| Non Currrent Assets Other | — | 48,366,000USD | 46,031,000USD | 766,000USD | 774,000USD | 780,000USD | 772,000USD | 846,000USD |
| Net Working Capital | — | 131,075,000USD | 148,565,000USD | 125,735,000USD | 115,330,000USD | 119,514,000USD | 161,194,000USD | 76,440,000USD |
| Unclassified Non Current Assets | — | -47,545,000USD | -45,266,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 1,793,000USD | 2,117,000USD | 2,436,000USD | 2,749,000USD | 3,057,000USD | 3,359,000USD | 3,657,000USD |
| Unclassified Equity | — | 501,663,000USD | 498,633,000USD | 417,182,000USD | 416,122,000USD | 415,211,000USD | 412,042,000USD | 313,931,000USD |
| Net Receivables | — | — | 1,257,000USD | 1,001,000USD | 890,000USD | 368,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 209,468,000USD | 181,454,000USD | 78,954,000USD | 113,290,000USD | 172,596,000USD | 203,157,000USD | 6,975,000USD | 23,521,000USD |
| Intangible Assets | 2,930,000USD | 3,245,000USD | 2,661,000USD | 84,000USD | 29,517,000USD | 29,517,000USD | — | — |
| Other Current Assets | 2,693,000USD | 1,863,000USD | 2,883,000USD | 127,000USD | 1,249,000USD | 837,000USD | 794,000USD | 1,369,000USD |
| Total Liab | 13,056,000USD | 14,320,000USD | 10,633,000USD | 11,207,000USD | 10,682,000USD | 3,914,000USD | 583,000USD | 3,078,000USD |
| Total Stockholder Equity | 196,412,000USD | 167,134,000USD | 68,321,000USD | 102,083,000USD | 161,914,000USD | 199,243,000USD | 6,392,000USD | 20,443,000USD |
| Other Current Liab | 6,229,000USD | 5,408,000USD | 2,732,000USD | 3,237,000USD | 2,448,000USD | 1,754,000USD | -133,000USD | 2,637,000USD |
| Common Stock | 54,000USD | 35,000USD | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 3,000USD | 19,000USD |
| Capital Stock | 54,000USD | 35,000USD | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 18,463,000USD | 21,523,000USD |
| Retained Earnings | -302,419,000USD | -244,980,000USD | -200,384,000USD | -159,964,000USD | -94,012,000USD | -46,760,000USD | -225,462,000USD | -210,470,000USD |
| Cash | 49,657,000USD | 162,798,000USD | 39,586,000USD | 24,127,000USD | 35,724,000USD | 168,598,000USD | 6,181,000USD | 19,371,000USD |
| Cash And Short Term Investments | 155,554,000USD | 170,292,000USD | 65,580,000USD | 84,370,000USD | 91,229,000USD | 168,598,000USD | 6,181,000USD | 21,867,000USD |
| Total Current Assets | 159,504,000USD | 172,155,000USD | 68,705,000USD | 86,146,000USD | 93,112,000USD | 169,435,000USD | 6,975,000USD | 23,236,000USD |
| Total Current Liabilities | 10,939,000USD | 10,961,000USD | 6,149,000USD | 5,740,000USD | 4,298,000USD | 2,915,000USD | 583,000USD | 3,078,000USD |
| Net Debt | -46,298,000USD | -158,315,000USD | -34,119,000USD | -17,743,000USD | -28,485,000USD | -167,511,000USD | -6,181,000USD | -19,371,000USD |
| Short Term Debt | 1,242,000USD | 1,124,000USD | 983,000USD | 917,000USD | 855,000USD | 88,000USD | — | — |
| Short Long Term Debt Total | 3,359,000USD | 4,483,000USD | 5,467,000USD | 6,384,000USD | 7,239,000USD | 1,087,000USD | — | — |
| Long Term Investments | 42,336,000USD | 0USD | 0USD | 17,886,000USD | 39,467,000USD | 745,000USD | — | — |
| Short Term Investments | 105,897,000USD | 7,494,000USD | 25,994,000USD | 60,243,000USD | 55,505,000USD | 0USD | 0USD | 2,496,000USD |
| Net Receivables | 1,257,000USD | — | 242,000USD | 486,000USD | 634,000USD | — | — | — |
| Accounts Payable | 3,468,000USD | 4,429,000USD | 2,434,000USD | 1,586,000USD | 954,000USD | 914,000USD | 716,000USD | 441,000USD |
| Property Plant Equipment Net | 3,933,000USD | 5,282,000USD | 6,560,000USD | 7,869,000USD | 8,890,000USD | 2,300,000USD | 459,000USD | 263,000USD |
| Property Plant Equipment Gross | 5,401,000USD | 6,388,000USD | 7,384,000USD | 7,869,000USD | 8,890,000USD | 1,240,000USD | 0USD | 263,000USD |
| Accumulated Other Comprehensive Income | 90,000USD | 2,000USD | -31,000USD | -688,000USD | -211,000USD | 0USD | 3,000USD | 5,000USD |
| Common Stock Shares Outstanding | 42,836,129shares | 20,592,847shares | 11,331,338shares | 11,259,615shares | 11,232,576shares | 7,233,913shares | 4,062,468shares | 2,560,444shares |
| Non Current Assets Total | 49,964,000USD | 9,299,000USD | 10,249,000USD | 27,144,000USD | 79,484,000USD | 33,722,000USD | 581,000USD | 285,000USD |
| Non Current Liabilities Total | 2,117,000USD | 3,359,000USD | 4,484,000USD | 5,467,000USD | 6,384,000USD | 999,000USD | 263,000USD | 0USD |
| Non Currrent Assets Other | 46,031,000USD | 772,000USD | 1,028,000USD | 1,305,000USD | 1,610,000USD | 1,905,000USD | 122,000USD | 22,000USD |
| Net Working Capital | 148,565,000USD | 161,194,000USD | 62,556,000USD | 80,406,000USD | 88,814,000USD | 166,520,000USD | 6,392,000USD | 20,158,000USD |
| Unclassified Non Current Assets | -45,266,000USD | — | — | -1,389,000USD | -31,127,000USD | -32,167,000USD | — | — |
| Unclassified Non Current Liabilities | 2,117,000USD | 3,359,000USD | 4,484,000USD | 5,467,000USD | 6,384,000USD | — | — | — |
| Unclassified Equity | 498,633,000USD | 412,042,000USD | 268,714,000USD | 262,713,000USD | 256,115,000USD | 245,981,000USD | 213,385,000USD | 209,366,000USD |
| Other Assets | — | — | 1USD | 1,389,000USD | 1,610,000USD | 1,905,000USD | -581,000USD | 22,000USD |
| Good Will | — | — | — | 0USD | 29,517,000USD | 29,517,000USD | — | — |
| Inventory | — | — | — | 1,163,000USD | 1,215,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 102,083,000USD | 132,397,000USD | 169,726,000USD | -12,071,000USD | -1,080,000USD |
| Unclassified Current Assets | — | — | — | — | -1,215,000USD | — | — | — |
| Non Current Liabilities Other | — | — | — | — | — | 999,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 162,000USD |
| Stock Based Compensation | 2,746,000USD |
| Change To Liabilities | 2,473,000USD |
| Change In Working Capital | -934,000USD |
| Operating Cash Flow | -36,732,000USD |
| Capital Expenditures | -332,000USD |
| Net Investments | 3,365,000USD |
| Investing Cash Flow | 3,033,000USD |
| Financing Cash Flow | 1,118,000USD |
| Change In Cash | -32,581,000USD |
| End Cash Flow | 17,821,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -17,782,000USD | -17,307,000USD | -13,258,000USD | -14,960,000USD | -11,914,000USD | -12,769,000USD | -11,219,000USD | -9,513,000USD |
| Depreciation | 90,000USD | 93,000USD | 88,000USD | 98,000USD | 83,000USD | 82,000USD | 84,000USD | 83,000USD |
| Stock Based Compensation | 1,362,000USD | 1,043,000USD | 1,047,000USD | 903,000USD | 833,000USD | 904,000USD | 931,000USD | 1,064,000USD |
| Other Non Cash Items | 93,000USD | -48,000USD | -123,000USD | -99,000USD | 97,000USD | -20,000USD | -77,000USD | 243,000USD |
| Change In Working Capital | -5,106,000USD | -731,000USD | -206,000USD | 1,808,000USD | -3,812,000USD | 2,495,000USD | 1,847,000USD | 436,000USD |
| Total Cash From Operating Activities | -21,343,000USD | -16,950,000USD | -12,452,000USD | -12,250,000USD | -14,713,000USD | -9,308,000USD | -8,434,000USD | -7,687,000USD |
| Capital Expenditures | 0USD | -24,000USD | -4,000USD | -22,000USD | -44,000USD | 0USD | -8,000USD | -55,000USD |
| Free Cash Flow | -21,343,000USD | -16,974,000USD | -12,456,000USD | -12,272,000USD | -14,757,000USD | -9,308,000USD | -8,442,000USD | -7,742,000USD |
| Investments | -14,721,000USD | -26,884,000USD | -6,506,000USD | -47,723,000USD | -58,354,000USD | 22,500,000USD | -29,390,000USD | 2,945,000USD |
| Total Cashflows From Investing Activities | -14,721,000USD | -26,908,000USD | -6,506,000USD | -47,723,000USD | -58,354,000USD | 22,500,000USD | -29,390,000USD | 2,945,000USD |
| Total Cash From Financing Activities | 1,144,000USD | 80,964,000USD | 13,000USD | 8,000USD | 1,730,000USD | 97,849,000USD | 0USD | 42,092,000USD |
| Change In Cash | -34,920,000USD | 37,106,000USD | -18,945,000USD | -59,965,000USD | -71,337,000USD | 111,041,000USD | -37,824,000USD | 37,350,000USD |
| Begin Period Cash Flow | 50,402,000USD | 13,296,000USD | 31,496,000USD | 91,461,000USD | 162,798,000USD | 52,502,000USD | 90,326,000USD | 52,231,000USD |
| End Period Cash Flow | 15,482,000USD | 50,402,000USD | 12,551,000USD | 31,496,000USD | 91,461,000USD | 163,543,000USD | 52,502,000USD | 89,581,000USD |
| Other Cashflows From Financing Activities | -272,000USD | — | 13,000USD | — | -185,000USD | 3,807,000USD | 11,000USD | -83,000USD |
| Unclassified Financing Cash Flow | 1,416,000USD | — | — | — | 1,915,000USD | — | — | 42,110,000USD |
| Issuance Of Capital Stock | — | 80,964,000USD | 0USD | — | — | 94,042,000USD | 0USD | — |
| Dividends Paid | — | — | — | — | — | — | -11,000USD | -11,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | 76,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -57,439,000USD | -44,596,000USD | -40,420,000USD | -65,952,000USD | -47,252,000USD | -33,978,000USD | -14,992,000USD | -20,729,000USD |
| Depreciation | 362,000USD | 332,000USD | 341,000USD | 248,000USD | 117,000USD | 196,000USD | 279,000USD | 115,000USD |
| Stock Based Compensation | 3,826,000USD | 4,125,000USD | 6,092,000USD | 6,688,000USD | 10,362,000USD | 9,746,000USD | 943,000USD | 3,429,000USD |
| Other Non Cash Items | -173,000USD | 324,000USD | 569,000USD | 32,020,000USD | 1,737,000USD | 9,940,000USD | -4,000USD | -76,000USD |
| Change In Working Capital | -2,941,000USD | 4,007,000USD | -4,139,000USD | 539,000USD | 534,000USD | 629,000USD | -1,872,000USD | -5,972,000USD |
| Total Cash From Operating Activities | -56,365,000USD | -35,808,000USD | -37,557,000USD | -26,457,000USD | -34,502,000USD | -23,407,000USD | -15,646,000USD | -23,233,000USD |
| Capital Expenditures | -94,000USD | -63,000USD | -45,000USD | -120,000USD | -596,000USD | -884,000USD | -16,000USD | -119,000USD |
| Free Cash Flow | -56,459,000USD | -35,871,000USD | -37,602,000USD | -26,577,000USD | -35,098,000USD | -24,291,000USD | -15,662,000USD | -23,352,000USD |
| Investments | -139,397,000USD | 19,155,000USD | 20,244,000USD | 14,950,000USD | -97,598,000USD | 2,835,000USD | 2,500,000USD | 18,546,000USD |
| Total Cashflows From Investing Activities | -139,491,000USD | 19,155,000USD | 53,107,000USD | 14,950,000USD | -98,194,000USD | 2,835,000USD | 2,484,000USD | 18,427,000USD |
| Total Cash From Financing Activities | 82,715,000USD | 139,865,000USD | -91,000USD | -90,000USD | -228,000USD | 189,401,000USD | 500,000USD | 2,985,000USD |
| Issuance Of Capital Stock | 80,964,000USD | 136,006,000USD | 0USD | — | -1,000USD | 179,453,000USD | 39,599,623USD | 2,853,000USD |
| Change In Cash | -113,141,000USD | 123,212,000USD | 15,459,000USD | -11,597,000USD | -132,924,000USD | 168,829,000USD | -13,162,000USD | -1,799,000USD |
| Begin Period Cash Flow | 163,543,000USD | 40,331,000USD | 24,872,000USD | 36,469,000USD | 169,393,000USD | 564,000USD | 19,393,000USD | 21,192,000USD |
| End Period Cash Flow | 50,402,000USD | 163,543,000USD | 40,331,000USD | 24,872,000USD | 36,469,000USD | 169,393,000USD | 6,231,000USD | 19,393,000USD |
| Other Cashflows From Financing Activities | -185,000USD | 3,859,000USD | 53,107,000USD | 14,950,000USD | -98,194,000USD | 103,220,000USD | 500USD | 132,000USD |
| Unclassified Financing Cash Flow | 1,936,000USD | — | -53,107,000USD | -14,950,000USD | 98,194,000USD | -6,150,000USD | -37,431,123USD | 1,537,000USD |
| Sale Purchase Of Stock | — | — | -91,000USD | -90,000USD | -228,000USD | 94,000,000USD | — | 2,985,000USD |
| Unclassified Investing Cash Flow | — | — | 32,908,000USD | — | — | -2,835,000USD | -2,500,000USD | -18,546,000USD |
| Change To Liabilities | — | — | — | 631,000USD | 40,000USD | -768,000USD | -2,497,000USD | -6,162,000USD |
| Other Cashflows From Investing Activities | — | — | — | 15,070USD | -97,598USD | 3,719,000USD | 2,500,000USD | 18,546,000USD |
| Net Borrowings | — | — | — | — | 0USD | -1,669,000USD | -1,669,000USD | -1,669,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 168,829,000USD | -13,162,000USD | -1,821,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | -9,940,000USD | — | — |
| Change To Account Receivables | — | — | — | — | — | — | 17,000USD | 49,000USD |
| Change To Inventory | — | — | — | — | — | — | -17,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.